BidaskClub Lowers Clorox Company (The) (CLX) to Strong Sell

Clorox Company (The) (NYSE:CLX) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Monday, July 24th.

A number of other brokerages have also commented on CLX. Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price for the company in a research report on Tuesday, July 4th. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price target for the company in a research note on Monday, April 24th. Jefferies Group LLC set a $138.00 target price on Clorox Company (The) and gave the stock a “hold” rating in a research note on Wednesday, May 3rd. Finally, BMO Capital Markets restated a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. Clorox Company (The) has a consensus rating of “Hold” and an average target price of $129.05.

Clorox Company (NYSE:CLX) opened at 137.73 on Monday. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The company’s 50-day moving average price is $133.55 and its 200 day moving average price is $134.12. The company has a market capitalization of $17.78 billion, a PE ratio of 25.82 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the company posted $1.30 EPS. The business’s quarterly revenue was up 2.9% on a year-over-year basis. On average, equities research analysts anticipate that Clorox Company will post $5.67 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “BidaskClub Lowers Clorox Company (The) (CLX) to Strong Sell” was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this report can be accessed at https://www.com-unik.info/2017/08/19/clorox-company-the-clx-lowered-to-strong-sell-at-bidaskclub-updated-updated-updated.html.

A number of hedge funds and other institutional investors have recently made changes to their positions in CLX. Korea Investment CORP raised its position in shares of Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the period. Crossvault Capital Management LLC raised its position in shares of Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares during the period. Park National Corp OH raised its position in shares of Clorox Company (The) by 6.5% in the first quarter. Park National Corp OH now owns 5,440 shares of the company’s stock valued at $733,000 after buying an additional 331 shares during the period. HighPoint Advisor Group LLC raised its stake in Clorox Company (The) by 3.0% in the fourth quarter. HighPoint Advisor Group LLC now owns 43,247 shares of the company’s stock valued at $5,509,000 after buying an additional 1,245 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the last quarter. Institutional investors own 69.83% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit